These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


477 related items for PubMed ID: 18448456

  • 1. The probiotic Escherichia coli strain Nissle 1917 induces gammadelta T cell apoptosis via caspase- and FasL-dependent pathways.
    Guzy C, Paclik D, Schirbel A, Sonnenborn U, Wiedenmann B, Sturm A.
    Int Immunol; 2008 Jul; 20(7):829-40. PubMed ID: 18448456
    [Abstract] [Full Text] [Related]

  • 2. Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling.
    Sturm A, Rilling K, Baumgart DC, Gargas K, Abou-Ghazalé T, Raupach B, Eckert J, Schumann RR, Enders C, Sonnenborn U, Wiedenmann B, Dignass AU.
    Infect Immun; 2005 Mar; 73(3):1452-65. PubMed ID: 15731043
    [Abstract] [Full Text] [Related]

  • 3. Polyinosinic-polycytidylic acid-mediated stimulation of human gammadelta T cells via CD11c dendritic cell-derived type I interferons.
    Kunzmann V, Kretzschmar E, Herrmann T, Wilhelm M.
    Immunology; 2004 Jul; 112(3):369-77. PubMed ID: 15196204
    [Abstract] [Full Text] [Related]

  • 4. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N, Tang L, Li X, Wu D, Li W, Chen X, Cui L, Ba D, He W.
    Immunol Lett; 2009 Aug 15; 125(2):105-13. PubMed ID: 19539651
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of caspases maintains the antineoplastic function of gammadelta T cells repeatedly challenged with lymphoma cells.
    Ferrarini M, Consogno G, Rovere P, Sciorati C, Dagna L, Resta D, Rugarli C, Manfredi AA.
    Cancer Res; 2001 Apr 01; 61(7):3092-5. PubMed ID: 11306492
    [Abstract] [Full Text] [Related]

  • 6. Elevated numbers of SCART1+ gammadelta T cells in skin inflammation and inflammatory bowel disease.
    Fink DR, Holm D, Schlosser A, Nielsen O, Latta M, Lozano F, Holmskov U.
    Mol Immunol; 2010 May 01; 47(9):1710-8. PubMed ID: 20381152
    [Abstract] [Full Text] [Related]

  • 7. Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy.
    Schilbach K, Frommer K, Meier S, Handgretinger R, Eyrich M.
    J Immunother; 2008 May 01; 31(9):896-905. PubMed ID: 18832998
    [Abstract] [Full Text] [Related]

  • 8. Requirement for CD4+ T cells in the gammadelta T cell proliferative response to Daudi Burkitt's lymphoma.
    Burns J, Lobo S, Bartholomew B.
    Cell Immunol; 1996 Nov 25; 174(1):19-24. PubMed ID: 8929450
    [Abstract] [Full Text] [Related]

  • 9. Regulation of gammadelta T cell survival by soluble HLA-I: involvement of CD8 and activating killer Ig-like receptors.
    Poggi A, Contini P, Catellani S, Setti M, Murdaca G, Zocchi MR.
    Eur J Immunol; 2005 Sep 25; 35(9):2670-8. PubMed ID: 16114098
    [Abstract] [Full Text] [Related]

  • 10. Innate anti-breast cancer immunity of apoptosis-resistant human gammadelta-T cells.
    Guo BL, Liu Z, Aldrich WA, Lopez RD.
    Breast Cancer Res Treat; 2005 Sep 25; 93(2):169-75. PubMed ID: 16187237
    [Abstract] [Full Text] [Related]

  • 11. Innate immune functions of human gammadelta T cells.
    Beetz S, Wesch D, Marischen L, Welte S, Oberg HH, Kabelitz D.
    Immunobiology; 2008 Sep 25; 213(3-4):173-82. PubMed ID: 18406365
    [Abstract] [Full Text] [Related]

  • 12. Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy.
    Kondo M, Sakuta K, Noguchi A, Ariyoshi N, Sato K, Sato S, Sato K, Hosoi A, Nakajima J, Yoshida Y, Shiraishi K, Nakagawa K, Kakimi K.
    Cytotherapy; 2008 Sep 25; 10(8):842-56. PubMed ID: 19016372
    [Abstract] [Full Text] [Related]

  • 13. Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways.
    Grabig A, Paclik D, Guzy C, Dankof A, Baumgart DC, Erckenbrecht J, Raupach B, Sonnenborn U, Eckert J, Schumann RR, Wiedenmann B, Dignass AU, Sturm A.
    Infect Immun; 2006 Jul 25; 74(7):4075-82. PubMed ID: 16790781
    [Abstract] [Full Text] [Related]

  • 14. Gut immune stimulation by non pathogenic Gram(+) and Gram(-) bacteria. Comparison with a probiotic strain.
    Dogi CA, Galdeano CM, Perdigón G.
    Cytokine; 2008 Mar 25; 41(3):223-31. PubMed ID: 18248820
    [Abstract] [Full Text] [Related]

  • 15. Type I IFN-mediated enhancement of anti-leukemic cytotoxicity of gammadelta T cells expanded from peripheral blood cells by stimulation with zoledronate.
    Watanabe N, Narita M, Yokoyama A, Sekiguchi A, Saito A, Tochiki N, Furukawa T, Toba K, Aizawa Y, Takahashi M.
    Cytotherapy; 2006 Mar 25; 8(2):118-29. PubMed ID: 16698685
    [Abstract] [Full Text] [Related]

  • 16. Fas-dependent, activation-induced cell death of gammadelta cells.
    Gan YH, Wallace M, Malkovsky M.
    J Biol Regul Homeost Agents; 2001 Mar 25; 15(3):277-85. PubMed ID: 11693437
    [Abstract] [Full Text] [Related]

  • 17. Anti-inflammatory effects of plumbagin are mediated by inhibition of NF-kappaB activation in lymphocytes.
    Checker R, Sharma D, Sandur SK, Khanam S, Poduval TB.
    Int Immunopharmacol; 2009 Jul 25; 9(7-8):949-58. PubMed ID: 19374955
    [Abstract] [Full Text] [Related]

  • 18. Human gammadelta T cells produce the protease inhibitor and antimicrobial peptide elafin.
    Marischen L, Wesch D, Schröder JM, Wiedow O, Kabelitz D.
    Scand J Immunol; 2009 Dec 25; 70(6):547-52. PubMed ID: 19906197
    [Abstract] [Full Text] [Related]

  • 19. Workshop cluster 1+ gammadelta T-cell receptor T cells from calves express high levels of interferon-gamma in response to stimulation with interleukin-12 and -18.
    Price SJ, Sopp P, Howard CJ, Hope JC.
    Immunology; 2007 Jan 25; 120(1):57-65. PubMed ID: 17034425
    [Abstract] [Full Text] [Related]

  • 20. Split immune response after oral vaccination of mice with recombinant Escherichia coli Nissle 1917 expressing fimbrial adhesin K88.
    Remer KA, Bartrow M, Roeger B, Moll H, Sonnenborn U, Oelschlaeger TA.
    Int J Med Microbiol; 2009 Nov 25; 299(7):467-78. PubMed ID: 19467927
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.